Human Cytomegalovirus Compromises Development of Cerebral Organoids

被引:50
|
作者
Brown, Rebecca M. [1 ,2 ]
Rana, Pranav S. J. B. [1 ,2 ]
Jaeger, Hannah K. [1 ,2 ]
O'Dowd, John M. [1 ,2 ]
Balemba, Onesmo B. [1 ,2 ]
Fortunato, Elizabeth A. [1 ,2 ]
机构
[1] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA
[2] Univ Idaho, Ctr Reprod Biol, Moscow, ID 83843 USA
关键词
cerebral organoid; cortical development; human cytomegalovirus; induced pluripotent stem cells; neural marker expression; NEURAL PROGENITOR CELLS; SENSORINEURAL HEARING-LOSS; PLURIPOTENT STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; NEURONAL DIFFERENTIATION; CMV INFECTION; BRAIN; REPLICATION; MODEL; SUSCEPTIBILITY;
D O I
10.1128/JVI.00957-19
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Congenital human cytomegalovirus (HCMV) infection causes a broad spectrum of central and peripheral nervous system disorders, ranging from microcephaly to hearing loss. These ramifications mandate the study of virus-host interactions in neural cells. Neural progenitor cells are permissive for lytic infection. We infected two induced pluripotent stem cell (iPSC) lines and found these more primitive cells to be susceptible to infection but not permissive. Differentiation of infected iPSCs induced de novo expression of viral antigens. iPSCs can be cultured in three dimensions to generate cerebral organoids, closely mimicking in vivo development. Mock-or HCMV-infected iPSCs were subjected to a cerebral organoid generation protocol. HCMV IE1 protein was detected in virus-infected organoids at 52 days postinfection. Absent a significant effect on organoid size, infection induced regions of necrosis and the presence of large vacuoles and cysts. Perhaps more in parallel with the subtler manifestations of HCMV-induced birth defects, infection dramatically altered neurological development of organoids, decreasing the number of developing and fully formed cortical structure sites, with associated changes in the architectural organization and depth of lamination within these structures, and manifesting aberrant expression of the neural marker beta-tubulin III. Our observations parallel published descriptions of infected clinical samples, which often contain only sparse antigen-positive foci yet display areas of focal necrosis and cellular loss, delayed maturation, and abnormal cortical lamination. The parallels between pathologies present in clinical specimens and the highly tractable three-dimensional (3D) organoid system demonstrate the utility of this system in modeling host-virus interactions and HCMV-induced birth defects. IMPORTANCE Human cytomegalovirus (HCMV) is a leading cause of central nervous system birth defects, ranging from microcephaly to hearing impairment. Recent literature has provided descriptions of delayed and abnormal maturation of developing cortical tissue in infected clinical specimens. We have found that infected induced pluripotent stem cells can be differentiated into three-dimensional, viral protein-expressing cerebral organoids. Virus-infected organoids displayed dramatic alterations in development compared to those of mock-infected controls. Development in these organoids closely paralleled observations in HCMV-infected clinical samples. Infection induced regions of necrosis, the presence of larger vacuoles and cysts, changes in the architectural organization of cortical structures, aberrant expression of the neural marker beta-tubulin III, and an overall reduction in numbers of cortical structure sites. We found clear parallels between the pathologies of clinical specimens and virus-infected organoids, demonstrating the utility of this highly tractable system for future investigations of HCMV-induced birth defects.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Human cerebral organoids recapitulate gene expression programs of fetal neocortex development
    Camp, J. Gray
    Badsha, Farhath
    Florio, Marta
    Kanton, Sabina
    Gerber, Tobias
    Wilsch-Braeuninger, Michaela
    Lewitus, Eric
    Sykes, Alex
    Hevers, Wulf
    Lancaster, Madeline
    Knoblich, Juergen A.
    Lachmann, Robert
    Paeaebo, Svante
    Huttner, Wieland B.
    Treutlein, Barbara
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (51) : 15672 - 15677
  • [22] The analysis of neurodevelopmental disorders by the generation of 3D cerebral organoids mimicking the human cerebral development
    Jung, M.
    Schiller, J.
    Gimpel, A. S.
    Hartmann, A.
    Giegling, I.
    Rujescu, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S194 - S195
  • [23] CRX haploinsufficiency compromises photoreceptor precursor translocation and differentiation in human retinal organoids
    Deng Pan
    Xiao Zhang
    Kangxin Jin
    Zi-Bing Jin
    Stem Cell Research & Therapy, 14
  • [24] CRX haploinsufficiency compromises photoreceptor precursor translocation and differentiation in human retinal organoids
    Pan, Deng
    Zhang, Xiao
    Jin, Kangxin
    Jin, Zi-Bing
    STEM CELL RESEARCH & THERAPY, 2023, 14 (01)
  • [25] Effects of matrigel on growth and development of cerebral organoids
    Chang, Ning
    He, Jiahui
    Guo, Yunxia
    Huang, Yan
    Zhao, Xiangwei
    MATERIALS EXPRESS, 2022, 12 (04) : 616 - 627
  • [26] Cerebral Organoids as an Experimental Platform for Human Neurogenomics
    Nowakowski, Tomasz J.
    Salama, Sofie R.
    CELLS, 2022, 11 (18)
  • [27] Glioblastoma Model Using Human Cerebral Organoids
    Ogawa, Junko
    Pao, Gerald M.
    Shokhirev, Maxim N.
    Verma, Inder M.
    CELL REPORTS, 2018, 23 (04): : 1220 - 1229
  • [28] Induction of Expansion and Folding in Human Cerebral Organoids
    Li, Yun
    Muffat, Julien
    Omer, Attya
    Bosch, Irene
    Lancaster, Madeline A.
    Sur, Mriganka
    Gehrke, Lee
    Knoblich, Juergen A.
    Jaenisch, Rudolf
    CELL STEM CELL, 2017, 20 (03) : 385 - +
  • [29] Human cerebral organoids: the ethical stance of scientists
    Andrea Lavazza
    Alice Andrea Chinaia
    Stem Cell Research & Therapy, 14
  • [30] Human cerebral organoids: the ethical stance of scientists
    Lavazza, Andrea
    Chinaia, Alice Andrea
    STEM CELL RESEARCH & THERAPY, 2023, 14 (01)